Lescol
Brand names,
Lescol
Analogs
Lescol
Brand Names Mixture
Lescol
Chemical_Formula
C24H26FNO4
Lescol
RX_link
http://www.rxlist.com/cgi/generic2/fluvastatinxl.htm
Lescol
fda sheet
Lescol
msds (material safety sheet)
Lescol
Synthesis Reference
F. G. Kathawala, U.S. Pat. 4,739,073 (1988)
Lescol
Molecular Weight
411.466 g/mol
Lescol
Melting Point
194-197oC
Lescol
H2O Solubility
0.46 mg/L
Lescol
State
Solid
Lescol
LogP
4.98
Lescol
Dosage Forms
Capsules; Tablets (extended-release)
Lescol
Indication
For management as an adjunct to diet to reduce elevated total-C, LDL-C, apo B, and TG levels in patients with primary hypercholesterolemia and mixed dyslipidemia
Lescol
Pharmacology
Fluvastatin, the first synthetically-prepared HMG-CoA reductase inhibitor, is used as an antilipemic to lower cholesterol and triglyceride levels associated with primary hypercholesterolemia and mixed dyslipidemia (Fredrickson types IIa and IIb) and to slow the progression of coronary atherosclerosis in patients with coronary artery disease. Although similar to lovastatin, simvastatin, and pravastatin, Fluvastatin has a shorter half-life, no active metabolites, extensive protein binding, and minimal CSF penetration.
Lescol
Absorption
24% (range 9%-50%).
Lescol
side effects and Toxicity
Variety of GI complaints and an increase in transaminase values (i.e., SGOT and SGPT).
Lescol
Patient Information
PATIENT INFORMATION
Patients should be advised to report promptly unexplained muscle pain, tenderness or
weakness, particularly if accompanied by malaise or fever.
Women should be informed that if they become pregnant while receiving Lescol or Lescol
XL the drug should be discontinued immediately to avoid possible harmful effects on a
developing fetus from a relative deficit of cholesterol and biological products derived
from cholesterol. In addition, Lescol or Lescol XL should not be taken during nursing.
Lescol
Organisms Affected
Humans and other mammals